Question explored with the scientific record
Conversation so far
- 1 Causes of raised liver gammaGT
- 2 Could my meds or supplements raise GGT, and how long after stopping?
Answered on this page ↓
Could my meds or supplements raise GGT, and how long after stopping?
The short version: yes, some medications and supplements can raise GGT, and levels usually fall within weeks to months after stopping, but the evidence here barely touches the practical question of which ones and how fast.
The evidence you retrieved is mostly about substances that lower GGT or protect the liver, not raise it. Quercetin [1], vitamin E [3], selenium [6], zinc [9], Arabic gum [10], vitamin C [11], betaine [12], and L-carnitine [14] all show protective effects in animal models. That tells you they are unlikely to be the cause of a high GGT. The one supplement that clearly can raise GGT is turmeric with piperine: a 2025 case report documents a woman who developed severe liver injury with a GGT of 68 U/L after five months of daily turmeric shots [13]. Aloe preparations have also caused toxic hepatitis with elevated liver enzymes [7], and Chinese skullcap in the supplement Move Free caused a case of DILI [8].
Among medications, the evidence names several that cause cholestatic (bile-duct) injury with high GGT: atorvastatin (a case with GGT 591 U/L that normalized within two months of stopping) [31], ticlopidine (GGT 1616 U/L, normalized within six weeks) [36], cefazolin [38], NSAIDs including celecoxib [33] and others [39], hydralazine [34], antithyroid drugs [37], and ivermectin [4]. The pattern is consistent: GGT rises during exposure and falls after discontinuation, usually over 4–12 weeks depending on the drug and the severity of injury.
| Agent | GGT rise documented | Time to normalize after stopping |
|---|---|---|
| Atorvastatin | 591 U/L (case) [31] | ~2 months |
| Ticlopidine | 1616 U/L (case) [36] | ~6 weeks |
| Turmeric/piperine | 68 U/L (case) [13] | ~15 weeks with steroids |
| Celecoxib | Elevated (case) [33] | ~1–6 months |
| Ivermectin | Elevated (case) [4] | ~3 months with steroids |
| Hydralazine | Elevated (case) [34] | ~4 weeks |
What is missing from this retrieval is the most common medication causes of raised GGT: acetaminophen at high doses, antibiotics like amoxicillin-clavulanate (the leading cause of DILI in Iceland [15]), and anti-tuberculosis drugs (the leading cause in Nepal [43]). The retrieval also lacks data on common supplements like green tea extract, kava, or ashwagandha, all known to raise liver enzymes. The evidence is thin and skewed toward case reports of rare drugs rather than the everyday culprits.
My call: if your GGT is high, look first at medications and supplements you started in the past few months. Most will resolve within 4–12 weeks of stopping the offending agent, but the evidence here does not cover the most common causes. Confidence: low, because the retrieval misses the drugs and supplements that actually cause most GGT elevations.
Sources examined 43
-
Quercetin alleviates liver fibrosis via regulating glycolysis of liver sinusoidal endothelial cells and neutrophil infiltration
Quercetin alleviates liver fibrosis in a carbon tetrachloride–induced mouse model by inhibiting glycolysis in liver sinusoidal endothelial cells and reducing CXCL1-driven neutrophil infiltration, thereby improving liver injury markers.
DOI: 10.17305/bb.2024.10530 -
The progression of chronicity and autoimmune hepatitis in recurrent drug-induced liver injury
A retrospective cohort study of 57 patients with recurrent drug-induced liver injury (DILI) caused by different drugs, assessing progression to chronic DILI and autoimmune hepatitis (AIH); second episodes showed shorter latency and often milder biochemical injury but higher chro…
DOI: 10.1016/j.clinre.2022.102009 -
Vitamin E inhibits hepatic oxidative stress, toxicity and hyperproliferation in rats treated with the renal carcinogen ferric nitrilotriacetate
This in vivo rat study demonstrates that pretreatment with vitamin E dose-dependently mitigates Fe-NTA–induced hepatic oxidative stress, toxicity, and hyperproliferation by preserving glutathione and antioxidant enzyme activities, reducing lipid peroxidation and DNA synthesis ma…
DOI: 10.1179/135100005X21642 -
Ivermectin drug induced liver injury
A 70-year-old woman developed jaundice and cholestatic hepatitis 3 weeks after starting oral ivermectin 12 mg daily for COVID-19 prophylaxis; liver biopsy showed DILI pattern, RUCAM score 8, and prednisone normalized liver enzymes within 3 months.
DOI: 10.7196/samj.2023.v113i6.624 -
Effect of retinoic acid, butylated hydroxytoluene, propylgallate and selenium on 2-acetylaminofluorene induced hepatotoxicity
In Sprague-Dawley rats, dietary retinoic acid enhances 2-AAF–induced hepatotoxicity and hepatocarcinogenesis, while supplementation with butylated hydroxytoluene, propyl gallate, and selenium mitigates liver damage, highlighting complex interactions in chemoprevention/dietary mo…
DOI: 10.1016/0304-3835(85)90157-0 -
Protective Effect of Selenium against Methotrexate Induced Hepatotoxicity
Selenium supplementation mitigates methotrexate-induced hepatotoxicity in mice by lowering liver enzymes (ALT, AST, ALP) and restoring total protein, indicating antioxidant protection against MTX-induced liver injury.
DOI: 10.47191/ijcsrr/v5-i4-09 -
Aloe-induced Toxic Hepatitis
This study reports three cases of aloe-induced toxic hepatitis in women who had taken aloe preparations, highlighting the need for awareness of potential hepatotoxicity associated with herbal supplements.
DOI: 10.3346/jkms.2010.25.3.492 -
Chinese Skullcap in Move Free Arthritis Supplement Causes Drug Induced Liver Injury and Pulmonary Infiltrates
This study reports a case of drug-induced liver injury and pulmonary infiltrates in a patient following the use of the over-the-counter arthritis supplement Move Free, implicating Chinese skullcap as the likely cause.
DOI: 10.1155/2013/965092 -
Protective role of zinc in nickel induced hepatotoxicity in rats
This study investigates the protective role of zinc against nickel-induced hepatotoxicity in female Sprague Dawley rats, demonstrating that zinc supplementation can restore liver function and histoarchitecture altered by nickel exposure.
DOI: 10.1016/j.cbi.2004.09.012 -
Water Extract of Arabic Gum Ameliorates the Gentamicin-Induced Nephrotoxicity, Hepatotoxicity, Oxidative Stress Markers andCytokine Levels in Mice
The study demonstrates that oral water extract of Arabic gum mitigates gentamicin-induced nephrotoxicity and hepatotoxicity in mice, reduces oxidative stress, and modulates inflammatory cytokine expression, supporting its potential as a dietary supplement for protection against …
DOI: 10.70135/seejph.vi.3033 -
Preventive Effects of Vitamin C on Diethylnitrosamine-induced Hepatotoxicity in Smp30 Knockout Mice
This study investigates the hepatoprotective effects of vitamin C against diethylnitrosamine-induced hepatotoxicity in Smp30 knockout mice, demonstrating that vitamin C supplementation significantly improves lifespan and reduces liver damage compared to vitamin C-deficient contr…
DOI: 10.21873/invivo.11209 -
Effect of betaine supplementation on changes in hepatic metabolism of sulfur-containing amino acids and experimental cholestasis induced by α-naphthylisothiocyanate
Betaine supplementation prevents alpha-naphthylisothiocyanate (ANIT)-induced cholestasis in mice by sustaining hepatic S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) levels and modulating sulfur-containing amino acid metabolism, thereby reducing hepatotoxicity.
DOI: 10.1016/j.fct.2004.12.015 -
Drug-Induced Liver Injury Associated with Turmeric and Piperine: A Case and Review
A 40-year-old woman developed severe turmeric-piperine–associated drug-induced liver injury after five months of daily turmeric wellness shots, illustrating hepatotoxic risk from turmeric-containing supplements and the potential role of piperine in enhancing toxicity.
DOI: 10.1159/000543679 -
Carnitine deficiency: a possible risk factor in paracetamol hepatotoxicity
This study investigates the role of carnitine deficiency as a potential risk factor in paracetamol-induced hepatotoxicity in male Swiss albino rats, demonstrating that carnitine supplementation can mitigate the toxic effects of paracetamol.
DOI: 10.1007/s00204-008-0330-x -
Incidence, Presentation, and Outcomes in Patients With Drug-Induced Liver Injury in the General Population of Iceland
This study investigates the incidence, clinical presentation, and outcomes of drug-induced liver injury (DILI) in the general population of Iceland, revealing a crude annual incidence of 19.1 cases per 100,000 inhabitants and identifying amoxicillin-clavulanate as the most commo…
DOI: 10.1053/j.gastro.2013.02.006 -
Gamma‐glutamyl Transferase as Oncofetal Marker of Experimental Hepatocarcinogenesis in the Rat
This study investigates the role of gamma-glutamyl transferase (y-GTase) as an oncofetal marker during the stages of hepatocarcinogenesis in rats, revealing its resurgence in specific liver cell populations and its potential as a sensitive marker for liver cancer development.
DOI: 10.1111/j.1365-3083.1978.tb03975.x -
Albumin and Gamma-Glutamyl Transferase as Biomarkers for Differentiating Systemic Juvenile Idiopathic Arthritis from Reactive Arthritis
This study identifies albumin and gamma-glutamyl transferase (GGT) as significant clinical indicators for differentiating systemic juvenile idiopathic arthritis (sJIA) from reactive arthritis (ReA), developing a clinical prediction model that demonstrates excellent diagnostic ef…
DOI: 10.2147/JIR.S522233 -
Gamma Glutamyl Transferase in domestic animals
This study investigates the distribution and clinical significance of Gamma Glutamyl Transferase (GGT) in various domestic animals, highlighting its role as a diagnostic marker for hepato-biliary disorders and kidney damage.
DOI: 10.1007/BF02214900 -
No Relevant Association Between Coronary Artery Ectasia and Mean Platelet Volume, Gamma Glutamyl Transferase and Uric Acid Levels
This study investigates the lack of association between mean platelet volume, gamma glutamyl transferase, uric acid levels, and coronary artery ectasia in a large patient population, finding no significant differences between patients with isolated CAE and those with normal coro…
DOI: 10.1016/j.jacc.2013.08.584 -
Serum Gamma-Glutamyl Transferase Levels are Associated with Metabolic Syndrome in Community-Dwelling Individuals
This study investigates the association between serum gamma-glutamyl transferase (GGT) levels and metabolic syndrome (MetS) in a community-dwelling population in Japan, finding that higher GGT levels are significantly associated with MetS and its components, particularly in rela…
DOI: 10.5551/jat.no414 -
Serum gamma-glutamyl transferase activity: new high-risk criteria in acute coronary syndrome patients?
This study evaluates the prognostic value of serum gamma-glutamyl transferase (GGT) activity in predicting major adverse cardiac events (MACE) in patients with acute coronary syndrome (ACS) during their follow-up in a coronary care unit.
DOI: 10.1097/MCA.0b013e32830eab8c -
Association between serum gamma-glutamyl transferase and serum uric acid levels in Chinese females: A cross-sectional study
This study investigates the association between serum gamma-glutamyl transferase (GGT) levels and serum uric acid levels in middle-aged and elderly Chinese females, finding a significant correlation where higher GGT levels are associated with increased prevalence of hyperuricemi…
DOI: 10.1080/07435800.2017.1300809 -
Interleukin-33 overexpression is associated with gamma-glutamyl transferase in biliary atresia
This study investigates the correlation between serum levels of interleukin-33 (IL-33) and gamma-glutamyl transferase (GGT) in infants with biliary atresia, revealing that elevated IL-33 levels may serve as a novel biomarker for the disease.
DOI: 10.1016/j.cyto.2012.10.035 -
Prognostic significance of serum gamma-glutamyl transferase in patients with intermediate hepatocellular carcinoma treated with transcatheter arterial chemoembolization
This study investigates the prognostic significance of serum gamma-glutamyl transferase (GGT) levels in patients with intermediate hepatocellular carcinoma undergoing transcatheter arterial chemoembolization, finding that high GGT levels correlate with poorer overall survival ou…
DOI: 10.1097/MEG.0b013e32834902dd -
MYO5B mutations cause cholestasis with normal serum gamma‐glutamyl transferase activity in children without microvillous inclusion disease
This study identifies MYO5B mutations in five children with a progressive familial intrahepatic cholestasis-like phenotype characterized by normal serum gamma-glutamyl transferase activity, suggesting that MYO5B deficiency can lead to isolated cholestasis without intestinal dise…
DOI: 10.1002/hep.28779 -
Association of Serum Gamma-Glutamyl Transferase and Ferritin with the Metabolic Syndrome
This study investigates the relationship between serum gamma-glutamyl transferase (GGT), ferritin levels, and the risk of metabolic syndrome in a cohort of 1024 individuals from the Chinese Yi ethnic group, finding that elevated levels of both biomarkers are significantly associ…
DOI: 10.1155/2015/741731 -
Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication
This study investigates the correlation between baseline gamma-glutamyl transferase (cGT) levels and the development of hepatocellular carcinoma (HCC) in non-cirrhotic patients who have successfully eradicated hepatitis C virus (HCV), finding that high cGT levels are a significa…
DOI: 10.1016/j.jhep.2014.02.022 -
A203 ACTIVITY OF MBX-8025, A POTENT AND SELECTIVE PPAR-δ AGONIST, ON BIOCHEMICAL MARKERS OF CHOLESTASIS
The study investigates the effects of MBX-8025, a selective PPAR-delta agonist, on biochemical markers of cholestasis, demonstrating significant decreases in alkaline phosphatases, gamma glutamyl transferase, and total bilirubin across three clinical studies.
DOI: 10.1093/jcag/gwy008.204 -
Apoplastic gamma-glutamyl transferase activity encoded by GGT1 and GGT2 is important for vegetative and generative development
This study investigates the roles of apoplastic gamma-glutamyl transferase isoforms GGT1 and GGT2 in Arabidopsis thaliana, revealing their importance in vegetative and generative development, particularly in seed yield and trichome formation.
DOI: 10.1016/j.plaphy.2017.03.007 -
1370 CAN AST VALUES BE USED INSTEAD OF ALT TO CALCULATE THE PATTERN OF DRUG INDUCED LIVER INJURY (DILI)?
This study investigates the use of aspartate aminotransferase (AST) as a reliable alternative to alanine aminotransferase (ALT) for calculating the R ratio in drug-induced liver injury (DILI), demonstrating a high correlation and consistency in results across various patient dem…
DOI: 10.1016/s0168-8278(12)61381-6 -
Cholestatic hepatitis induced by atorvastatin: a case-report
A 77-year-old man on atorvastatin developed cholestatic hepatitis that resolved after stopping the drug, illustrating a rare idiosyncratic statin-induced liver injury and underscoring the importance of postmarketing safety surveillance.
DOI: 10.4081/itjm.2007.1.29 -
In Vitro Inhibition of the Bile Salt Export Pump Correlates with Risk of Cholestatic Drug-Induced Liver Injury in Humans
This study investigates the in vitro inhibition of the human bile salt export pump (BSEP) by 85 pharmaceuticals and its correlation with the risk of cholestatic drug-induced liver injury (DILI) in humans, revealing that certain physicochemical properties of drugs are associated …
DOI: 10.1124/dmd.111.040758 -
Cholestatic Hepatitis with Small Duct Injury Associated with Celecoxib
A case report of cholestatic hepatitis with small-duct injury temporally linked to Celecoxib use in a 34-year-old Hispanic woman, with liver function normalization after discontinuation and histology suggesting small-duct sclerosing cholangitis-like changes.
DOI: 10.1155/2013/315479 -
Hydralazine-Induced Cholestatic Hepatitis
This case report describes a 63-year-old African-American female who developed cholestatic hepatitis attributed to hydralazine, which improved significantly after discontinuation of the drug, highlighting the need for careful monitoring of liver function in patients on hydralazi…
DOI: 10.1097/MJT.0b013e31817fde85 -
High-Content Imaging in Human and Rat Hepatocytes Using the Fluorescent Dyes CLF and CMFDA Is Not Specific Enough to Assess BSEP/Bsep and/or MRP2/Mrp2 Inhibition by Cholestatic Drugs
This study investigates the specificity of fluorescent dyes CLF and CMFDA in assessing BSEP and MRP2 inhibition in human and rat hepatocytes, revealing that neither dye is specific enough for accurate assessment of cholestatic drug effects.
DOI: 10.1089/aivt.2015.0014 -
Reduced multidrug resistance-associated protein 2 in ticlopidine-induced cholestatic liver injury
Case report of ticlopidine-induced cholestatic hepatitis in an elderly woman where reduced MRP2 immunoreactivity in liver tissue supported the diagnosis of drug-induced liver injury and suggested MRP2 as a potential diagnostic marker with a mechanistic link to PXR signaling.
DOI: 10.1016/j.dld.2019.10.013 -
Clinical Characteristics and Outcomes of Patients With Antithyroid Drug–Related Liver Injury
A systematic review synthesizing clinical characteristics, patterns of liver injury, outcomes, and management of antithyroid drug–related liver injury (ATD-DILI) across 271 patients from 100 studies, highlighting differences between carbimazole/methimazole and propylthiouracil a…
DOI: 10.1210/jendso/bvad133 -
Identification and Characterization of Cefazolin-Induced Liver Injury
This study identifies and characterizes a new syndrome of liver injury associated with cefazolin, revealing that it can occur after a single intravenous dose and is characterized by a cholestatic biochemical pattern and a self-limited clinical course.
DOI: 10.1016/j.cgh.2014.11.036 -
NSAID-induced liver damage with cholestasis
NSAIDs can cause drug-induced liver injury with a cholestatic pattern; this piece reviews prevalence, mechanisms, clinical features, and management, highlighting stopping NSAIDs and using ursodeoxycholic acid (UDCA) when cholestasis develops.
DOI: 10.33667/2078-5631-2021-23-37-48 -
Sicca Complex and Cholangiostatic Jaundice in Two Members of a Family Probably Caused by Thiabendazole
This is a case-report describing two members of a single family who developed sicca complex and cholestatic jaundice after thiabendazole exposure, with discussion of potential autoimmune mechanisms and implications for drug-induced autoimmune liver/eye disease.
DOI: 10.1016/S0161-6420(79)35334-9 -
Wichtige Differenzialdiagnose akuter Hepatitiden - Cholestatische Hepatitis nach Konsum von Ecstasy
A 30-year-old man developed cholestatic hepatitis after MDMA (Ecstasy) use, improved with ursodeoxycholic acid, but with persistent biochemical abnormalities after two months, highlighting ecstasy-induced hepatotoxicity as a differential diagnosis for acute hepatitis in young ad…
DOI: meta/10.1055/s-2005-870670 -
Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation
This study investigates the frequency, clinical presentation, and outcomes of drug-induced liver injury (DILI) in liver transplant recipients, finding that DILI is rare but often resolves without severe consequences after drug cessation.
DOI: 10.1002/lt.23424 -
Etiology and Pattern of Drug Induced Liver Injury in a Tertiary Care Hospital of Nepal
A prospective cross-sectional study of 27 drug-induced liver injury (DILI) patients at a Nepalese tertiary hospital found antitubercular drugs as the leading cause and a predominance of mixed-pattern liver injury.
DOI: 10.3126/nmcj.v21i3.26466